AVINZA 30 mg 505 (Avinza 30 mg)
Generic Name: morphine
Pill imprint AVINZA 30 mg 505 has been identified as Avinza 30 mg.
Avinza is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Avinza 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Avinza
- Generic Name:
- morphine
- Imprint:
- AVINZA 30 mg 505
- Strength:
- 30 mg
- Color:
- Yellow / White
- Size:
- 16.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Ligand Pharmaceuticals
- National Drug Code (NDC):
- 64365-0505
- Inactive Ingredients:
- ammonio methacrylate copolymers
fumaric acid
povidone
sodium lauryl sulfate
sugar spheres
magnesium silicate
More about Avinza (morphine)
Consumer resources
- Other brands: MS Contin, Kadian, Roxanol, MSIR, More (6) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
